$10.22
0.313.13%
Last update: Oct 26, 4:00 PM
Core Laboratories Inc
CLBNYSE
Core Laboratories (CLB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Core Laboratories (CLB) last issued guidance on July 29, 2026 for Q3 2026. The company guided earnings per share in the range of $0.12 - $0.2, compared to a consensus EPS estimate of $0.17. Core Laboratories also guided revenue in the range of $128.5M - $135.5M for the period.
Compared to prior guidance, Core Laboratories raised its revenue forecast from a prior range of $123M - $131M.
Core Laboratories has issued 17 guidance updates between October 26, 2022 and July 29, 2026. During this period, the company raised its outlook 6 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.09 | $0.10 | $0.19 | $0.19 |
| Actual | $0.11 | $0.06 | $0.21 | $0.22 |
| Surprise | +22.2% | -40.0% | +10.5% | +15.8% |
| Revenue | ||||
| Estimate | $126.8M | $124.5M | $131.2M | $129.8M |
| Actual | $124.6M | $121.8M | $138.3M | $134.5M |
| Surprise | -1.74% | -2.20% | +5.41% | +3.65% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.16 | $0.19 | $0.11 | $0.27 |
| Revenue | ||||
| Consensus | $131.9M | $134.2M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $0.11 | $0.09 | 22.2 % |
| Q1 | Apr 29, 2026 | $0.06 | $0.10 | -40.0 % |
| Q4 | Feb 4, 2026 | $0.21 | $0.19 | 10.5 % |
| Q3 | Oct 22, 2025 | $0.22 | $0.19 | 15.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $124.61M | $126.81M | -1.74 % |
| Q1 | Apr 29, 2026 | $121.80M | $124.54M | -2.20 % |
| Q4 | Feb 4, 2026 | $138.26M | $131.15M | 5.41 % |
| Q3 | Oct 22, 2025 | $134.52M | $129.78M | 3.65 % |
